{"id":2032817,"date":"2023-09-15T05:20:02","date_gmt":"2023-09-15T09:20:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/lack-of-transparency-among-gop-gripes-over-medicare-drug-price-negotiation-rules\/"},"modified":"2023-09-15T05:21:49","modified_gmt":"2023-09-15T09:21:49","slug":"lack-of-transparency-among-gop-gripes-over-medicare-drug-price-negotiation-rules","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/lack-of-transparency-among-gop-gripes-over-medicare-drug-price-negotiation-rules\/","title":{"rendered":"GOP&#8217;s lack of transparency fuels concerns about Medicare drug price negotiation rules."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">24<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Flack-of-transparency-among-gop-gripes-over-medicare-drug-price-negotiation-rules%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2032817&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>Democrats and Republicans \u2063Clash Over Prescription Drug \u2062Costs<\/h2>\n<p>Democrats\u2062 and Republicans both\u200b acknowledge the rising costs of\u2064 prescription drugs as a top priority in \u2064their\u200d legislative agendas. However, they strongly disagree on the level of market regulation needed to achieve lower costs.<\/p>\n<p>The latest battleground\u2064 for this issue is the new authorities granted to the secretary of the Department of Health and Human\u200c Services (HHS) by President Joe Biden\u2019s Inflation Reduction Act. HHS Secretary Xavier Becerra \u200dis the first to have\u200d the power to oversee Medicare&#8217;s negotiation of drug prices with\u200c manufacturers. As the\u2064 largest\u200d bulk purchaser \u200cof prescription drugs in the \u2064nation, Medicare&#8217;s involvement\u200d is\u200c significant.<\/p>\n<h3>Transparency Concerns<\/h3>\n<p>In late August, the Centers for Medicare\u2062 and Medicaid Services (CMS) announced the first 10 drugs selected \u200bfor the negotiation\u200d program. However, congressional Republicans \u200dand industry leaders argue that there is \u200ca lack of transparency in the \u200bdrug selection process.<\/p>\n<blockquote>\n<p>&#8220;We\u2064 want greater transparency. That&#8217;s \u200bthe big issue in this\u2063 whole pricing scheme\u2062 right now,&#8221; \u200dsaid Rep. Virginia Foxx\u2064 (R-NC), chairwoman of the House Committee\u200b on Education and the Workforce.\u200c She is concerned that the secretive selection process will eventually impact prices in\u2064 the private\u2063 and employer-funded \u200chealthcare system. &#8220;We need more transparency, along \u200cwith less government control over what is happening in the marketplace.&#8221;<\/p>\n<\/blockquote>\n<h3>A Long-Running Battle<\/h3>\n<p>The ability of Medicare to <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/lack-of-transparency-among-gop-gripes-over-medicare-drug-price-negotiation-rules\/\" title=\"GOP's lack of transparency fuels concerns about Medicare drug price negotiation rules.\">directly negotiate prescription\u2064 drug prices<\/a> has been a contentious political issue for \u2064years. The Republican-controlled Congress\u200b gained the upper hand in 2003 by \u2064creating Medicare Part D, which \u2063prohibited the\u200d HHS secretary from negotiating prices. However, these provisions\u200c were overturned by the Biden administration&#8217;s Inflation\u2062 Reduction Act.<\/p>\n<p>Democrats \u2063view\u2062 the new Medicare negotiation program as a safeguard\u200b for seniors. Sen. Bob Casey (D-PA), chairman of the\u200c Senate Committee on Aging, stated, &#8220;Pharmaceutical companies\u200b will no longer\u2062 be able to charge Medicare recipients \u2064unfair prices for the medications they need, and millions\u2063 of Americans will\u2064 see lower drug \u2064costs as a result.&#8221;<\/p>\n<h3>Lack of\u200b Transparency<\/h3>\n<p>The pharmaceutical\u2062 industry has long criticized Medicare\u2064 negotiating drug prices\u200d as a form of federal price \u200bcontrols. The current\u2063 lack of\u2064 transparency in the selection process further fuels their complaints.<\/p>\n<blockquote>\n<p>&#8220;We don&#8217;t have any perspective into the decision-making process because Congress said it \u2064could all be exempt from the normal rulemaking process,&#8221; explained Joel White, president of the Council for Affordable Health Coverage. He believes that new\u200c rules are being constructed behind closed doors, without input from pharmaceutical companies.<\/p>\n<\/blockquote>\n<p>Opponents of the\u2063 Medicare negotiations argue that the law will lead to a\u200c decline\u2063 in research and development funds for new pharmaceuticals. A study from the \u200dUniversity of Chicago estimated that price controls could result in\u200d a $663 billion decrease in investment for\u200d research and development, potentially preventing the introduction of\u2062 135 new drugs.<\/p>\n<p>The debate over prescription \u200cdrug costs and market regulation continues to be a \u2064contentious issue, with both sides advocating for their respective positions.<\/p>\n<p> <\/p>\n<h2> What are the differing views on\u2064 the\u200d role of the pharmaceutical industry \u2064in addressing the issue of high prescription drug prices<\/h2>\n<p><span>  T drugs are available, how they are priced, and how they are distributed,&#8221; she added.<\/p>\n<p>The lack of transparency raises concerns about potential favoritism in the drug selection process, as well as the possibility of excluding certain\u2062 drugs that may be essential \u200cfor certain patient populations.\u200c Critics argue that without proper\u2064 oversight and accountability, the negotiation program may not achieve its desired goal of <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/inflation-complicates-bidens-path-back-to-the-white-house\/\" title=\"Inflation hinders Biden's return to the White House.\">lowering \u200dprescription drug costs<\/a>.<\/p>\n<h3>Market Regulation<\/h3>\n<p>Democrats argue that increased market regulation\u2063 is necessary to\u2064 address the rising costs of prescription drugs. They believe that allowing Medicare to\u200c <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/biden-pushes-congress-to-lower-cost-of-prescription-drugs\/\" title=\"Biden Pushes Congress To Lower Cost Of Prescription Drugs\">negotiate drug prices<\/a> will help drive down costs and ensure affordable access for all Americans,\u2064 particularly seniors who rely heavily on prescription medications.<\/p>\n<p>On \u2062the other\u2062 hand, Republicans emphasize the importance of \u200bfree-market principles in\u200d addressing the issue. They argue that removing regulations and increasing competition will spur \u2063innovation, lower costs,\u2064 and\u200b provide more choices for consumers. They believe \u2062that market forces, rather than government intervention, are crucial for driving down prescription drug prices.<\/p>\n<h3>The Role of Pharmaceutical Industry<\/h3>\n<p>The pharmaceutical industry plays a \u2062significant role \u2063in the debate over prescription drug costs. \u2064While both Democrats and\u200d Republicans \u2064criticize the industry for \u200bits high prices, they differ on \u2064how to address the\u200b issue.<\/p>\n<p>Democrats advocate for measures such as allowing the importation of \u2064cheaper drugs from other countries and implementing price controls.\u200d They argue that\u2063 the pharmaceutical \u200dindustry&#8217;s profit motives have led to exorbitant pricing and that government intervention is needed \u200cto ensure affordability.<\/p>\n<p>Republicans, on the other hand, stress the importance of\u2063 incentivizing innovation and\u200c protecting intellectual property \u2064rights. \u200bThey believe that excessive \u200bregulation and price controls will stifle innovation and hinder the development of\u2062 life-saving drugs.<\/p>\n<h3>The Need for Bipartisanship<\/h3>\n<p>Despite\u200c their differences, Democrats and Republicans recognize the urgency of addressing the \u2064rising costs of \u2064prescription drugs. Both sides need to find common ground and work together to achieve a solution that benefits all Americans.<\/p>\n<p>Bipartisan efforts that prioritize affordability, innovation, and transparency \u200dare\u2062 essential. Collaboration between\u2064 lawmakers, healthcare providers, industry leaders, and patient advocacy groups can \u2064lead to comprehensive reforms \u200dthat address the root causes \u2064of\u2062 <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/house-panel-rejects-drug-price-control-bill-in-stunning-blow-to-pelosi\/\" title=\"House Panel Rejects Drug Price Control Bill In Stunning Blow To Pelosi\">high drug prices<\/a> and ensure access to affordable medications for all.<\/p>\n<p>In conclusion, \u200bthe rising\u200c costs\u200c of \u200dprescription \u2062drugs have become a contentious issue between Democrats and Republicans. While both sides agree on the importance of addressing this issue, they differ in their approaches\u2064 to regulating the market\u200d and controlling\u2064 prices. Finding common ground and \u2063implementing bipartisan\u2062 solutions is crucial to ensure affordable access to life-saving medications for all Americans.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Democrats and Republicans clash over market regulation to lower prescription drug costs, despite both prioritizing the issue. President Biden&#8217;s Inflation Reduction Act grants new authorities to the HHS Secretary, intensifying the disagreement between the parties.<\/p>\n","protected":false},"author":1,"featured_media":2032818,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[538],"tags":[],"class_list":["post-2032817","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-washington-examiner"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2032817","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2032817"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2032817\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2032818"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2032817"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2032817"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2032817"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}